Literature DB >> 1617924

A randomized, comparative study of the efficacy and tolerance of roxithromycin and doxycycline in the treatment of women with positive endocervical cultures for Chlamydia trachomatis and Mycoplasma spp. in an in vitro fertilization program.

J van Schouwenburg1, O de Bruyn, E Fourie, J van Rensburg, A Rodriques, I Pickard.   

Abstract

A total of 45 patients wishing to enter an in vitro fertilization program had positive endocervical cultures for Chlamydia trachomatis, 86 had positive cultures for Ureaplasma urealyticum, and 11 had positive cultures for Mycoplasma hominis. These patients and their consorts were randomly allocated to treatment with either roxithromycin or doxycycline. Both antibiotics were completely effective against C. trachomatis. In patients with U. urealyticum infection, roxithromycin was successful in 73% and doxycycline in 87% of cases. Mycoplasma hominis was eradicated in 100% of cases by doxycycline and in 85% of cases by roxithromycin. Doxycycline caused significantly more side effects than did roxithromycin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1617924     DOI: 10.1016/0732-8893(92)90140-o

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

1.  Enteric Coating Reduces Upper Gastrointestinal Adverse Reactions to Doxycycline.

Authors:  A Järvinen; S Nykänen; L Paasiniemi; T Hirsjärvi-Lahti; J Mattila
Journal:  Clin Drug Investig       Date:  1995-12       Impact factor: 2.859

Review 2.  Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

3.  Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women.

Authors:  Carol Páez-Canro; Juan Pablo Alzate; Lina M González; Jorge Andres Rubio-Romero; Anne Lethaby; Hernando G Gaitán
Journal:  Cochrane Database Syst Rev       Date:  2019-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.